520
Participants
Start Date
August 31, 2011
Primary Completion Date
July 31, 2014
Study Completion Date
January 31, 2015
PI-88
Lyophilized powder reconstituted to provide 160 mg of PI-88
Placebo
Lactose lyophilized powder
The Third Xiangya Hospital of Central South University, Changsha
Peking Union Medical College Hospital, Beijing
The General Hospital of People's Liberation Army (301 hospital), Beijing
Fudan University Zhongshan Hospital, Shanghai
Queen Mary Hospital, Hong Kong
Kyungpook National University Hospital (KNUH), Pusan
Pusan National University Hospital (PNUH), Pusan
Pusan National University Yangsan Hospital (PNUYH), Pusan
Asan Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Korea University Guro Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Seoul St. Mary Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Ajou University Hospital, Suwon
Changhua Christian Hospital, Changhua
Chang Gung Memorial Hospital, Kaohsiung City
E-Da Hospital, Kaohsiung City
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Chang Gung Memorial Hospital-Linkou Medical Centre, Taoyuan District
Lead Sponsor
Collaborators (1)
Medigen Biotechnology Corporation
INDUSTRY
Cellxpert Biotechnology Corp.
INDUSTRY